4-[cyclohexyl(propyl)amino]-N-quinolin-3-yl-benzamide
|
|
Descriptors Computed from Structure
Canonical SMILES:
CCCN(C1CCCCC1)C2=CC=C(C=C2)C(=O)NC3=CC4=CC=CC=C4N=C3
Isomeric SMILES
CCCN(C1CCCCC1)C2=CC=C(C=C2)C(=O)NC3=CC4=CC=CC=C4N=C3
InChI
InChI=1S/C25H29N3O/c1-2-16-28(22-9-4-3-5-10-22)23-14-12-19(13-15-23)25(29)27-21-17-20-8-6-7-11-24(20)26-18-21/h6-8,11-15,17-18,22H,2-5,9-10,16H2,1H3,(H,27,29)
Other Product
- 2,5-bis(chloranyl)cyclohexa-2,5-diene-1,4-diol
- 2,5-bis(chloranyl)benzene-1,4-diol
- 2,5-bis(chloranyl)phenol
- 2-oxidanylidenehexanedioic acid
- 2-oxidanylidene-3-sulfanyl-propanoic acid
- 3-oxidanylbenzaldehyde
- 3-azanylpropanal
- 2-azanyl-3-oxidanyl-benzoic acid
- 3-(3-hydroxyphenyl)propanoic acid
- 3-oxidanylidenehexanedioic acid
- (1S,4aS,8aS)-7-[1-isocyano-1-(4-methylphenyl)sulfonyl-ethyl]-1,4a-dimethyl-2,3,4,5,6,8a-hexahydronaphthalen-1-ol
- 4-methyl-N-[4-(4-phenylpiperazin-1-yl)butyl]benzenesulfonamide
- N-[(1R,2R,3S,4R,6R)-6-dodecoxy-4-(hydroxymethyl)-2,3-bis(oxidanyl)cyclohexyl]ethanamide
- (10R)-10-methyl-17-(2,4,4-trimethyl-3-oxidanidyl-1,3-oxazolidin-3-ium-2-yl)-2,4,7,8,9,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-one
- (10R)-10-methyl-17-(2,4,4-trimethyl-3-oxidanidyl-1,3-oxazolidin-2-yl)-2,4,7,8,9,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-one
- (4-heptan-2-ylpiperazin-1-yl)-[4-(morpholin-4-ylmethyl)phenyl]methanone
- (2R)-2-azanyl-N-[(2S,3R)-1-cyclohexyl-3-oxidanyl-4-(1H-1,2,4-triazol-5-ylsulfanyl)butan-2-yl]-3-methylsulfanyl-propanamide
- [(2Z)-2-(2-chloranyl-2-morpholin-4-ium-4-ylidene-ethylidene)-4,4-bis(fluoranyl)-7-methyl-3,5-dioxa-4-boranuidabicyclo[4.4.0]deca-1(6),7,9-trien-8-yl] ethanoate
- (2R,3R)-3-[tert-butyl(dimethyl)silyl]oxy-2-[(4-methoxyphenyl)amino]-3-phenyl-propan-1-ol
- tri(propan-2-yl)silyl (2S,6S)-1-methyl-6-(phenylmethyl)-3,6-dihydro-2H-pyridine-2-carboxylate
